Acute effects of MK801 on kainic acid-induced seizures in neonatal rats

References 

1. Albala, B.J., Moshe, S.L. and Okada, R., Kainic acid-induced seizures: A developmental study, Devel. Brain Res., 13 (1984) 139–148.
2. Annegers, J.F., Epidemiology of childhood onset seizures, In: W.E. Dodson and J.M. Pellock (Eds.), Pediatric Epilepsy: Diagnosis and Therapy, Demos Publications, New York, 1993.
3. Baram, T.Z. and Hirsch, E., EEG recording in neonatal and infant rats: some pitfalls and solutions, Dendron, 1 (1992) 39–46.
4. Berg, M., Bruhn, T., Johansen, F.F. and Diemer, N.H., Kainic acid-induced seizures and brain damage in the rat: different effects of NMDA- and AMPA receptor antagonists, Pharmacol. Toxicol., 73 (1993) 262–268.
5. Brosnan-Watters, G., Wozniak, D.F., Nardi, A. and Olney, J.W., Acute behavioral effects of MK-801 in the mouse. Pharmacol. Biochem. Behav., 53 (1996) 701–711.
6. Charriaut-Marlangue, C., Dessi, F. and Ben-Ari, Y., Inhibition of protein synthesis by the NMDA channel blocker MK-801, NeuroReport, 5 (1994) 1110–1112.
7. Chavko, M., Harabin, A.L., Braisted, J.C. and Pocotte, S.L., NMDA receptor antagonists aggravate hyperbaric oxygen-induced seizures in rats. Soc. Neurosci. Abstr., 21 (1995) 1969.
8. Chen, N.-H., Wang, C., Jobe, P.C. and Reith, M.A.E. Facilitation of amygdala kindling development and kindled seizures by metaphit. Epilepsia, 35 (1994) 927–934.
9. Clifford, D.B., Olney, J.W., Benz, A.M., Fuller, T.A. and Zorumski, C.F., Ketamine, phencyclidine and MK-801 protect against kainic acid-induced seizure-related brain damage. Epilepsia, 31 (1990) 382–390.
10. Clineschmidt, B.V., Martin, G.E., Bunting, P.R., Anticonvulsant activity of (+)-5-methyl-10, 11-dihydro-5H-dibenzo-(a,d)-cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties, Drug Devel. Res., 2 (1982) 123–134.
11. Debler, E.A., Lipovac, M.N., Lajtha, A., Zlokovic, B.V., Dunlop, D.S., Jacobson, A.E., Rice, K.C., de Costa, B. and Reith, M.A.E., Metaphit-induced audiogenic seizures in mice: I. Pharmacologic characterization, Epilepsia, 34 (1993) 201–210.
12. Farber N.B., Wozniak, D.F., Price M.T., Labruyere, J., Huss, J., St. Peter, H. and Olney, J.W., Age-specific neurotoxicity in the rat associated with NMDA receptor blockade, Biol. Psychiatr., 38 (1995) 788–796.
13. Fariello, R.G., Golden, G.T., Smith, G.G. and Reyes, P.F., Potentiation of kainic acid epileptogenicity and sparing from neuronal damage by an NMDA receptor antagonist, Epilepsy Res., 3 (1989) 206–213.
14. Fix, A.F., Horn, J.W., Wightman, K.A., Johnson, C.A., Long, G.G., Storts, R.W., Farber, N., Wozniak, D.F. and Olney, J.W., Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-d-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): A light and electron microscopic evaluation of the rat retrosplenial cortex, Exp. Neurol., 123 (1993) 204–215.
15. Gao, X.-M. and Tamminga, C.A., MK801 induces late regional increases in NMDA and kainate receptor binding in rat brain, J. Neural Transm., 101 (1995) 105–113.
16. Gilbert, M.E., The NMDA antagonist MK801 suppresses behavioral seizures, augments afterdischarges, but does not block development of perforant path kindling, Epilepsy Res., 17 (1994) 145–156.
17. Giovannini, M.G., Mutolo, D., Bianchi, A., Michelassi, A. and Pepeu, G., NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus: A microdialysis study, J. Neurosci., 14 (1994) 1358–1365.
18. Gorter, J.A. and de Bruin, J.P.C., Chronic neonatal MK-801 treatment results in an impairment of spatial learning in the adult rat, Brain Res., 580 (1992) 12–17.
19. Gorter, J.A., Titulaer, M., Bos, N.P.A. and Huisman, E., Chronic neonatal MK-801 administration leads to a long-lasting increase in seizure sensitivity during the early stages of hippocampal kindling, Neurosci. Lett., 134 (1991) 29–32.
20. Hargreaves, E.L. and Cain, D.P., Hyperactivity, hyperreactivity, and sensorimotor deficits induced by low doses of the N-methyl-d-aspartate non-competitive channel blocker MK801, Behav. Brain Res., 47 (1992) 23–33.
21. Hughes, P., Dragunow, M., Beilharz, E., Lawlor, P. and Gluckman, P., MK801 induces immediate-early gene proteins and BDNF mRNA in rat cerebrocortical neurones, Neuroreport, 4 (1993) 183–186.
22. Hughes, P., Young, D. and Dragunow, M. MK-801 sensitizes rats to pilocarpine induced limbic seizures and status epilepticus, Neuroreport, 4 (1993) 314–316.
23. Insel, T.R., Miller, L.P. and Gelhard, R.E., The ontogeny of excitatory amino acid receptors in rat forebrain: I. N-methyl-d-aspartate and quisqualate receptors, Neuroscience, 35 (1990) 31–43.
24. Kinsman, S.L., Wilson, M.A. and Johnston, M.V., The neuroprotective agent MK-801 increases expression of the N-methyl-d-aspartate receptor subunits NR2A and NR2B in neonatal rats, Ann. Neurol., 38 (1995) 530–531.
25. Lee, M.G., Choi, B.J., Lee, K.H., Chou, J.Y. and Kim, Y., Effects of pentobarbital, scopolamine and MK801 on pilocarpine-induced seizure and brain damage, Soc. Neurosci. Abstr., 21 (1995) 985.
26. Lees, G.J., Effects of anesthetics, anticonvulsants and glutamate antagonists on kainic acid-induced local and distal neuronal loss, J. Neurol. Sci., 108 (1992) 221–228.
27. McDonald, J.W., Silverstein, F.S. and Johnston, M.V., MK-801 pretreatment enhances N-methyl-d-aspartate mediated brain injury and increases brain N-methyl-d-aspartate recognition site binding in rats, Neuroscience, 38 (1990) 103–113.
28. McDonald, J.W., Johnston, M.V. and Young, A.B., Differential ontogenic development of the receptors comprising the NMDA receptor/channel complex in the rat hippocampus, Exp. Neurol., 110 (1990) 237–247.
29. McNamara, J.O., Russell, R.D., Rigsbee, L.D. and Bonhaus, D.W., Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models, Neuropharmacology, 27 (1988) 563–568.
30. Miller, L.P., Johnson, A.E., Gelhard, R.E. and Insel, T.R., The ontogeny of excitatory amino acid receptors in rat forebrain: II. Kainic acid receptors, Neuroscience, 35 (1990) 45–51.
31. Mintz, M., Rose, I.C. and Herberg, L.J., The effect of the NMDA receptor antagonist, MK-801, on the course and outcome of kindling, Pharmacol. Biochem. Behav., 35 (1990) 815–821.
32. Mikolasova, R., Velisek, L., Vorlicek, J. and Mares, P., Developmental changes of ketamine action against epileptic afterdischarges induced by hippocampal stimulation in rats, Devel. Brain Res., 81 (1994) 105–112.
33. Nitecka, L., Tremblay, E., Charton, G., Bouillot, J.P., Berger, M.L. and Ben-Ari, Y., Maturation of kainic acid seizure-brain damage syndrome in the rat: II. Histopathological sequelae, Neuroscience, 13 (1984) 1073–1094.
34. Olney, J.W. and Farber, N.B., Glutamate receptor dysfunction and schizophrenia, Arch. Gen. Psychiatr., 52 (1995) 998–1007.
35. O'Neill, S.K. and Bolger, G.T., Anticonvulsant activity of MK-801 and nimodipine alone and in combination against pentylenetetrazole and strychnine, Pharmacol. Biochem. Behav., 32 (1989) 595–600.
36. Ormandy, G.C., Jope, R.S. and Snead, O.C., III, Anticonvulsant action of MK-801 on the lithium-pilocarpine model of status epilepticus in rats, Exp. Neurol., 106 (1989) 172–180.
37. Rajachandran, L., Goodwin, G.A. and Spear, L.P., Psychopharmacological effects of MK-801 in infant and preweanling rat pups, Pharmacol. Biochem. Behav., 40 (1991) 291–295.
38. Ribak, C.E. and Navetta, M.S., An immature mossy fiber innervation of hilar neurons may explain their resistance to kainate-induced cell death in 15-day-old rats, Dev. Brain Res., 79 (1994) 47–62.
39. Sircar, R., Veliskova, J. and Moshe, S.L., Chronic neonatal phencyclidine treatment produces age-related changes in pentylenetetrazole-induced seizures, Devel. Brain Res., 81 (1994) 185–191.
40. Sparenborg, S., Brennecke, L.H., Jaax, N.K. and Braitman, D.J., Dizocilpine (MK-801) arrests status epilepticus and prevents brain damage induced by soman, Neuropharmacology, 31 (1992) 357–368.
41. Sperber, E.F., Haas, K.Z. and Moshe, S.L., Developmental aspects of status epilepticus, Intl. Pediatr., 7 (1992) 213–222.
42. Sperber, E.F., Haas, K.Z., Stanton, P.K. and Moshe, S.L., Resistance of the immature hippocampus to seizure-induced synaptic reorganization, Dev. Brain Res., 60 (1991) 88–93.
43. Stafstrom, C.E., Thompson, J.L. and Holmes, G.L., Kainic acid seizures in the developing brain: status epilepticus and spontaneous recurrent seizures, Devel. Brain Res., 65 (1992) 227–236.
44. Starr, M.S. and Starr, B.S., Paradoxical facilitation of pilocarpine-induced seizures in the mouse by MK801 and the nitric oxide synthesis inhibitor L-NAME, Pharmacol. Biochem. Behav., 45 (1993) 321–325.
45. Sun, X. and Larson, A.A., MK-801 and phencyclidine act at phencyclidine sites that are not linked to N-methyl-d-aspartate activity to inhibit behavioral sensitization to kainate, Neuroscience, 54 (1993) 773–779.
46. Tan, W.K.M., Williams, C.E., Gunn, A.J., Mallard, C.E. and Gluckman, P.D., Suppression of postischemic epileptiform activity with MK-801 improves neural outcome in fetal sheep, Ann. Neurol., 32 (1992) 677–682.
47. Tortella, F.C. and Hill, R.G., EEG seizure activity and behavioral neurotoxicity produced by (+)-MK801, but not by the glycine site antagonist L-687,414, in the rat, Neuropharmacology, 35 (1996) 441–446.
48. Tremblay, E., Nitecka, L., Berger, M.L. and Ben-Ari, Y., Maturation of kainic acid seizure-brain damage syndrome in the rat: I. Clinical, electrographic and metabolic observations, Neuroscience, 13 (1984) 1051–1072.
49. Tricklebank, M.D., Singh, L., Oles, R.J., Preston, D. and Iversen, S.D., The behavioral effects of MK-801: A comparison with antagonists acting noncompetitively and competitively at the NMDA receptor, Eur. J. Pharmacol., 167 (1989) 1127–1135.
50. Velisek, L., Veresova, S., Pobisova, H. and Mares, P., Excitatory amino acid antagonists and pentylenetetrazol-induced seizures during ontogenesis, Psychopharmacology, 104 (1991) 510–514.
51. Velisek, L., Kubova, H., Veliskova, J., Mares, P. and Ortova, M., Action of antiepileptic drugs against kainic acid-induced seizures and automatisms during ontogenesis in rats, Epilepsia, 33 (1992) 987–993.
52. Velisek, L., Veliskova, J., Ptachewich, Y., Shinnar, S. and Moshe, S.L., Effects of MK-801 and phenytoin on flurothyl-induced seizures during development, Epilepsia, 36 (1995) 179–185.
53. Veliskova, J., Velisek, L., Mares, P. and Rokyta, R., Ketamine suppresses both bicuculline- and picrotoxin-induced generalized tonic-clonic seizures during ontogenesis, Pharmacol. Biochem. Behav., 37 (1990) 667–674.
54. Walton, N.Y. and Treiman, D.M., Motor and electroencephalographic response of refractory experimental status epilepticus in rats to treatment with MK-801, diazepam, or MK-801 plus diazepam, Brain Res., 553 (1991) 97–104.
55. Wozniak, D.F., Olney, J.W., Kettinger, L., Price, M. and Miller, J.P., Behavioral effects of MK-801 in the rat, Psychopharmacology, 101 (1990) 47–56.
56. Zia-Gharib, F. and Webster, R.A., Effect of compounds modulating amino acid neurotransmission on the development and control of bicuculline-induced epileptogenic spiking in the rat, Neuropharmacology, 30 (1991) 995–1009.